Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 5—May 2015
Letter

Chikungunya, Dengue, and Malaria Co-Infection after Travel to Nigeria, India

Cite This Article

To the Editor: Arboviral infections, such as chikungunya and dengue, are endemic to South Asia. Concurrent infection of these viral infections with another vector-borne parasitic disease, malaria, is uncommon in India and would pose a challenge for medical diagnosis because of overlapping clinical symptoms. We present a case of multiple co-infections in a young man attending college in India after his return from Nigeria, a region endemic for chikungunya, dengue, and malaria.

After spending a 1-month vacation in Nigeria, a 21-year-old male asymptomatic Nigerian national arrived in Bengaluru, India, on September 5, 2014, to resume college. He developed febrile illness, chills, abdominal discomfort, headache, epigastric pain, and myalgias 6 days after his arrival. High-grade fever (103°F), icterus, and vomiting subsequently developed. He received treatment for his symptoms, and a physical examination revealed general weakness, pulse rate of 100 beats/min, and blood pressure of 140/70 mm Hg.

Various tests to assess his medical condition were conducted. A complete blood count showed a reduced platelet count of 68,000/mm3 (reference 1.5–5.0 mm3); findings of an abdominal ultrasonography were normal. Comprehensive kidney and liver function tests showed elevated values (blood urea, 53 mg/dL [reference 15–45 mg/dL]; serum creatinine, 1.66 mg/dL [reference 0.6–1.2 mg/dL]; aspartate aminotransferase, 67 IU/L [reference 5–34 IU/L]). Because the man had visited and returned from a region endemic for chikungunya, dengue, and malaria (1) and had a reduced platelet count, diagnostic tests for these infections were conducted. Accordingly, dengue nonstructural 1 antigen detection rapid test conducted on blood collected 2 days after symptom onset was positive. Microscopic observation of thick and thin blood smears (also from blood taken 2 days after symptom onset) showed the malaria parasite Plasmodium falciparum. Reverse transcription PCR (RT-PCR) on serum collected 2 days after symptom onset was conducted to detect chikungunya and dengue viral genomes. Test results were positive for both chikungunya and dengue viruses. However, IgM antibody capture–ELISA (MAC-ELISA) for detecting chikungunya and dengue viral antibodies was negative for both infections. In accordance with World Health Organization travel guidelines, a blood sample, taken 3 days after symptoms onset, was tested at the National Institute of Virology (Pune, India) for Ebola virus disease. This test used RT-PCR and real-time RT-PCR to detect Ebola virus nucleoprotein and polymerase genes and ruled out Ebola virus disease.

These tests were repeated with standard positive and negative controls to ensure no contamination and no false-positive results. RT-PCR for chikungunya and dengue viruses was performed by using virus gene–specific primers. RT-PCR for Japanese encephalitis and West Nile viruses also were conducted to rule out these cross-reacting arboviral infections that share common clinical manifestations with chikungunya and dengue. The failure of MAC-ELISA to detect chikungunya virus– and dengue virus–specific IgM was attributed to collection of the blood on day 2 after symptom onset, and thus the IgM would not have been generated to be detected by MAC-ELISA.

Fever similar to those common with malaria and typhoid are often exhibited with any of the arboviral infections that are endemic to Nigeria (1). Often these fevers are misdiagnosed as malarial fevers, and the opportunity to test for arboviral infections is missed. Dual infections of chikungunya and dengue are becoming more common in India (2,3), and there were earlier reports of dengue and malaria co-infection (4). Because these diseases are endemic to both Nigeria and India and because the incubation periods of infections vary, we do not know the exact location where the patient acquired any or all of these infections. Multiple infections in a single patient would drastically change the spectrum of clinical manifestations and thus complicate the diagnosis process. Our study particularly draws attention to understanding emerging arboviral infections and emphasizes the need for a multidimensional diagnostic approach in such clinical situations.

Top

Acknowledgments

We thank the Director of the National Institute of Virology. We also thank K.J. Pooja and T.H. Dharani Devi for their excellent technical help.

This work was supported by the Institutional funds from the National Institute of Virology.

Top

C.G. RautComments to Author , N.M. Rao, D.P. Sinha, H. Hanumaiah, and M.J. Manjunatha

Author affiliations: National Institute of Virology–Bangalore Unit, Bengaluru, India

Top

References

  1. Baba  M, Logue  CH, Oderinde  B, Abdulmaleek  H, Williams  J, Lewis  J, Evidence of arbovirus co-infection in suspected febrile malaria and typhoid patients in Nigeria. J Infect Dev Ctries. 2013;7:519 . DOIPubMed
  2. Chahar  HS, Bharaj  P, Dar  L, Guleria  R, Kabra  SK, Broor  S. Co-infections with chikungunya virus and dengue virus in Delhi, India. Emerg Infect Dis. 2009;15:107780. DOIPubMed
  3. Kalawat  U, Sharma  KK, Reddy  SG. Prevalence of dengue and chikungunya fever and their co-infection. Indian J Pathol Microbiol. 2011;54:8446 .PubMed
  4. Thangaratham  PS, Jeevan  MK, Rajendran  R, Samuel  PP, Tyagi  BK. Dual infection by dengue virus and Plasmodium vivax in Alappuzha district, Kerala, India. Jpn J Infect Dis. 2006;59:2112 .PubMed

Top

Cite This Article

DOI: 10.3201/eid2105.141804

Related Links

Top

Table of Contents – Volume 21, Number 5—May 2015

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

C.G. Raut, National Institute of Virology–Bangalore Unit, Molecular Virology, RGICD Premises, Near NIMHANS 1st Main Someshwara Nagar, Dharmaram College Post, Bangalore, Karnataka- 560029, India

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

Page created: April 06, 2015
Page updated: April 06, 2015
Page reviewed: April 06, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external